2024 annual financial data
Theravance Biopharma 2024 Operating margin
Theravance Biopharma 2024 operating margin with verified reported values.
Direct answer
Operating margin was -72.92%.
Operating income was -46,949,000 USD and net income was -56,418,000 USD.
Operating cash flow was -11,535,000 USD.
Get free Theravance Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 64,381,000 USD
- Operating income
- -46,949,000 USD
- Net income
- -56,418,000 USD
- Operating cash flow
- -11,535,000 USD